Medical/Pharmaceuticals

VISTA Eye Specialist Won Four (4) Prestigious Awards in 2021

PETALING JAYA, Malaysia, March 24, 2022 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of leading eye specialists inMalaysia established since 1999, has recently won the Golden Bull 2021 Outstanding SME Award to round off an eventful year.  

2022-03-24 08:00 2938

Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care

Huma acquires AstraZeneca's digital health platform AMAZE™ and AstraZeneca becomes a shareholder of Huma LONDON and NEW YORK, March 23, 2022 /PRNewswire/ -- Huma Therapeutics Limited , a global digital health technology company advancing digital-first care delivery and res...

2022-03-24 07:00 4409

LIMACORPORATE INTRODUCES L.E.A.R.N. THE NEW PLATFORM FOR A UNIQUE MEDICAL EDUCATION EXPERIENCE

UDINE, Italy, March 24, 2022 /PRNewswire/ -- Limacorporate S.p.A., leading global orthopedic manufacturer, is proud to introduce L.E.A.R.N. - LimaCorporate's Education and Resource Network. L.E.A.R.N. is a new and unique medical education experience, platform and network supporting surgeons in r...

2022-03-24 01:27 3879

Fosun International Announces 2021 Annual Results: Total Revenue Increased by 18% to RMB161.29 Billion, Striving to Pursue Steady and Sustainable Development

2021 Annual Results Summary and Highlights: * Total operating revenue for the year amounted to RMB161.29 billion, representing a year-on-year increase of 18%; profit attributable to owners of the parent reachedRMB10.09 billion, representing a year-on-year increase of 26%; * Profit of industria...

2022-03-23 23:01 4982

CARsgen Announces First Patient Enrollment in the Confirmatory Phase II Clinical Trial of CT041 in China

SHANGHAI, March 23, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors, today announced that CT041, an autologous CAR T-cell product candidate against...

2022-03-23 20:50 2682

CARsgen 2021 Annual Results: Steady Advancement in Innovative CAR T Products and Technologies

SHANGHAI, March 23, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2021 Annual Results. Business Highlights * CT053: complete...

2022-03-23 20:50 4602

Smartee Raises US$ 80 Million in Series D Funding

BEIJING, March 23, 2022 /PRNewswire/ -- In March 2022, Smartee announced that it has closed its Series D funding round ofUS$ 80 million. This round of financing was led by Beijing Taikang Investment, followed by China Resources Consumer Fund II, Jiaxing Science City, Zhangjiagang Industrial Inves...

2022-03-23 20:40 3419

Clarivate Patient Centricity Report Underscores Need for Evolution from Selling Products to Building Relationships

LONDON, March 23, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report,Walking the talk on patient centricity: An actionable and measurable model for life sc...

2022-03-23 16:00 2571

Telix Advances Development of Glioblastoma Therapy Program

MELBOURNE, Australia, March 23, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces it has made significant progress in advancing the Company's glioblastoma multiforme (GBM) therapy candidate TLX101 into the next stage of clinical development. TLX101 (4-L-...

2022-03-23 10:16 2889

Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

* First authorization of Novavax' COVID-19 vaccine in adolescent population received * Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorizedfor adolescents ≥12 to <18 inIndia * Authorization highligh...

2022-03-23 09:31 4719

Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA

HELSINKI, Finland, March 23, 2022 /PRNewswire/ --  Inside information Nanoform Finland Plc March 22, 2022 23:45 Finnish time / 22:45 Swedish time Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in theUSA NOT FOR RELEASE, PUBLICATION OR D...

2022-03-23 08:47 2313

InnoCare Releases 2021 Annual Results and Business Highlights

BEIJING, March 22, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2021 annual results as of31 December 2021. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, "We are delighted ...

2022-03-23 08:08 4080

VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease

SHANGHAI, March 22, 2022 /PRNewswire/ -- VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of innovative therapies for ocular diseases, today announced positive topline results from a Phase 2 clinical study of VVN001 in patients wi...

2022-03-23 08:00 2703

Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results

– Advancing key programs in HBV, CNS, and HIV – – Received first BLA approval for COVID-19 Treatment in China and added to China's latest COVID-19 Diagnosis and Treatment Guidelines– – Multiple clinical value drivers expected across the portfolio in 2022 and beyond – – Cash, bank balances, an...

2022-03-23 07:20 6137

Arum Therapeutics implements CDD Vault to streamline its research data and collaboration workflows.

SEOUL, South Korea and BURLINGAME, Calif., March 23, 2022 /PRNewswire/ -- Arum Therapeutics Inc. (Arum), a leading pharmaceutical company that specializes in the discovery of new molecules and molecule combinations to target novel oncology announced today that it had implementedCDD Vault, a resea...

2022-03-23 06:58 1770

Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively

The Proportion of Revenue from Innovative Products Continues to Increase Highlights: * Revenue for the year ended December 31, 2021 was RMB39,005 million, representing an increase of 28.70% YOY; * The proportion of revenue from new products as well as regions outside Mainland China and count...

2022-03-23 06:53 4224

Servatus launches Australia's first human study into the effects of live biotherapeutics on insomnia

* Study to look at the link between the gut microbiome and sleep, by treating patients who suffer from insomnia with live biotherapeutics * Phase I/II trial will run during 2022, with results expected in 2023 * Close to 15% of the Australian population suffer from insomnia, with sleep disord...

2022-03-23 05:00 3423

WuXi Biologics Achieved Record Growth and Profitability in 2021

Banner Year for Commercial Manufacturing Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million Gross Profit Increased by 90.6% Y-o-Y to RMB4,828.9 Million Net Profit Grew by 107.3% Y-o-Y to RMB3,508.6 Million Adjusted Net Profit Rose by 100.3% to RMB3,435.9 Million Total Backlog Grew 20.1% to ...

2022-03-23 00:38 3946

INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use

GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ -- PHASE Scientific International, LTD  (PHASE Scientific), a high-growth biotech company founded by bioengineers fromUCLA, announces that its INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) recei...

2022-03-23 00:00 2719

Jacobio Announces Annual Results of 2021, R&D Investment Increases 83%

BEIJING and SHANGHAI and BOSTON, March 22, 2022 /PRNewswire/ -- Jacobio Announced its 2021 annual results on 22 March. As a clinical-stage biotech company, Jacobio's revenue wasRMB152 million, which was generated from an out-licensing deal. Its R&D investment wasRMB421 million, showing an increas...

2022-03-22 22:50 2987
1 ... 587588589590591592593 ... 643